Stocks · Health care · Pharmaceutical Preparations

Turn Therapeutics Inc.

TTRX Clue Score40
United States Fiscal year ends December CIK 0002023016 Results filed 12 Aug 2026

What the insiders did Net buying

By person

8 insiders · 9 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Arthur F Golden
Director
$192.87K (3)
—
+$192.87K
360,602
1.21%
$1.26M
—
Abraham Chesed
Board Observer
$65.72K (1)
—
+$65.72K
1,447,268
4.86%
$5.07M
+1.0%
Zuraiz Chaudhary
See Remarks
$49.87K (5)
—
+$49.87K
12,500
0.0420%
$43.75K
—
Bradley Evan Burnam
Chief Executive Officer
—
—
—
300,000
1.01%
$1.05M
−50.0%
Martin William Dewhurst
Director
—
—
—
21,882
0.0735%
$76.59K
—
Andrew Gengos
Director
—
—
—
10,000
0.0336%
$35.00K
—
Kent Edward Kester
Director
—
—
—
10,000
0.0336%
$35.00K
—
Neilesh Shailesh Ghodadra
Chief Medical Officer
—
—
—
10,000
0.0336%
$35.00K
—